Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral plus intravenous tranexamic acid versus intravenous tranexamic acid alone after primary hip or knee arthroplasty
2015-002661-36Phase 4Completed
- Sponsor
- Belfast Health and Social Care Trust
- Start
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tranexamic acid in osteoarthritis (OA) (3 arms), sponsored by Belfast Health and Social Care Trust. Primary endpoint: Total indirect blood loss volume at 48 hours. Started Feb 2016; status: completed.
02
Drugs
tranexamic acid
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on 2015-002661-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002661-36.